These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16901912)

  • 1. Evolution of extended-spectrum beta-lactamases in a MutS-deficient Pseudomonas aeruginosa hypermutator.
    Driffield KL; Bostock JM; Miller K; O'neill AJ; Hobbs JK; Chopra I
    J Antimicrob Chemother; 2006 Oct; 58(4):905-7. PubMed ID: 16901912
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of extended-spectrum activity in TEM beta-lactamases in hyper-mutable, mutS Escherichia coli.
    Ellington MJ; Livermore DM; Pitt TL; Hall LM; Woodford N
    Clin Microbiol Infect; 2006 Aug; 12(8):800-3. PubMed ID: 16842578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Pseudomonas aeruginosa isolate producing the GES-5 extended-spectrum beta-lactamase.
    Wang C; Cai P; Chang D; Mi Z
    J Antimicrob Chemother; 2006 Jun; 57(6):1261-2. PubMed ID: 16617065
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of KPC-2-producing Pseudomonas aeruginosa isolates in China.
    Ge C; Wei Z; Jiang Y; Shen P; Yu Y; Li L
    J Antimicrob Chemother; 2011 May; 66(5):1184-6. PubMed ID: 21393139
    [No Abstract]   [Full Text] [Related]  

  • 5. Nationwide investigation of extended-spectrum beta-lactamases, metallo-beta-lactamases, and extended-spectrum oxacillinases produced by ceftazidime-resistant Pseudomonas aeruginosa strains in France.
    Hocquet D; Plésiat P; Dehecq B; Mariotte P; Talon D; Bertrand X;
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3512-5. PubMed ID: 20547814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pseudomonas aeruginosa and beta-lactam antibiotics at the time of Europe].
    Cavallo JD; Mérens A
    Pathol Biol (Paris); 2008; 56(7-8):435-8. PubMed ID: 19019568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTX-M and PER-1 group extended spectrum β-lactamases-producing Pseudomonas aeruginosa from the patients of lower respiratory tract infection.
    Saxena S; Banerjee G; Garg R; Singh M
    Indian J Med Microbiol; 2015; 33(1):191-2. PubMed ID: 25560041
    [No Abstract]   [Full Text] [Related]  

  • 8. Spread of the bla(IMP-13) gene in French Pseudomonas aeruginosa through sequence types ST621, ST308 and ST111.
    Fournier D; Jeannot K; Robert-Nicoud M; Muller E; Cholley P; van der Mee-Marquet N; Plésiat P
    Int J Antimicrob Agents; 2012 Dec; 40(6):571-3. PubMed ID: 23089049
    [No Abstract]   [Full Text] [Related]  

  • 9. Prediction of the evolution of ceftazidime resistance in extended-spectrum beta-lactamase CTX-M-9.
    Delmas J; Robin F; Carvalho F; Mongaret C; Bonnet R
    Antimicrob Agents Chemother; 2006 Feb; 50(2):731-8. PubMed ID: 16436733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of PER-1 extended-spectrum beta-lactamase producing Pseudomonas aeruginosa clinical isolates of the international clonal complex CC11 from Hungary and Serbia.
    Libisch B; Poirel L; Lepsanovic Z; Mirovic V; Balogh B; Pászti J; Hunyadi Z; Dobák A; Füzi M; Nordmann P
    FEMS Immunol Med Microbiol; 2008 Dec; 54(3):330-8. PubMed ID: 19049645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquisition of plasmid-borne blaIMP-19 gene by a VIM-1-positive Pseudomonas aeruginosa of the sequence type 235 epidemic lineage.
    Pollini S; Antonelli A; Venturelli C; Maradei S; Veggetti A; Bracco S; Rumpianesi F; Luzzaro F; Rossolini GM
    J Antimicrob Chemother; 2013 Mar; 68(3):722-4. PubMed ID: 23152479
    [No Abstract]   [Full Text] [Related]  

  • 12. Providencia stuartii with VIM-1 metallo-beta-lactamase.
    Miriagou V; Tzouvelekis LS; Flevari K; Tsakiri M; Douzinas EE
    J Antimicrob Chemother; 2007 Jul; 60(1):183-4. PubMed ID: 17517828
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro antibacterial activity of a new cephalosporin, FR295389, against IMP-type metallo-beta-lactamase-producers.
    Takeda S; Ikeda F; Hatano K
    J Antibiot (Tokyo); 2008 Jan; 61(1):36-9. PubMed ID: 18305358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissemination of Pseudomonas aeruginosa producing SPM-1-like and IMP-1-like metallo-beta-lactamases in hospitals from southern Brazil.
    Martins AF; Zavascki AP; Gaspareto PB; Barth AL
    Infection; 2007 Dec; 35(6):457-60. PubMed ID: 18034208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of an extended spectrum beta-lactamase producing Pseudomonas aeruginosa from a patient in a Sydney hospital.
    Bell SM; Pham JN; Gatus BJ; Poirel L; Nordmann P
    Pathology; 2007 Feb; 39(1):189-90. PubMed ID: 17365844
    [No Abstract]   [Full Text] [Related]  

  • 16. Emergence of blaGES-5 in clinical colistin-only-sensitive (COS) Pseudomonas aeruginosa strain in Brazil.
    da Fonseca EL; Vieira VV; Cipriano R; Vicente AC
    J Antimicrob Chemother; 2007 Mar; 59(3):576-7. PubMed ID: 17284538
    [No Abstract]   [Full Text] [Related]  

  • 17. Metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates in Tunisia.
    Mansour W; Poirel L; Bettaieb D; Bouallegue O; Boujaafar N; Nordmann P
    Diagn Microbiol Infect Dis; 2009 Aug; 64(4):458-61. PubMed ID: 19631102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of PER-1 producing clinical isolates of Pseudomonas aeruginosa in Japan and their susceptibility to doripenem.
    Yamano Y; Nishikawa T; Fujimura T; Yutsudou T; Tsuji M; Miwa H
    J Antibiot (Tokyo); 2006 Dec; 59(12):791-6. PubMed ID: 17323646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug-resistant Pseudomonas aeruginosa isolate co-expressing extended-spectrum beta-lactamase PER-1 and metallo-beta-lactamase VIM-2 from Turkey.
    Yakupogullari Y; Poirel L; Bernabeu S; Kizirgil A; Nordmann P
    J Antimicrob Chemother; 2008 Jan; 61(1):221-2. PubMed ID: 17981831
    [No Abstract]   [Full Text] [Related]  

  • 20. Beta-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres).
    Dubois V; Arpin C; Dupart V; Scavelli A; Coulange L; André C; Fischer I; Grobost F; Brochet JP; Lagrange I; Dutilh B; Jullin J; Noury P; Larribet G; Quentin C
    J Antimicrob Chemother; 2008 Aug; 62(2):316-23. PubMed ID: 18467306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.